Kalb Michael Wayne
Chief Financial Officer · 5 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-15 | CPRX | CATALYST PHARMACEUTICALS, INC. | D | 13,665 | $31.50 | $430,447.50 | filing |
| 2026-01-05 | CPRX | CATALYST PHARMACEUTICALS, INC. | Option exercise | 7,139 | — | — | filing |
| 2026-01-05 | CPRX | CATALYST PHARMACEUTICALS, INC. | Tax withholding | 2,080 | — | — | filing |
| 2025-11-21 | CPRX | CATALYST PHARMACEUTICALS, INC. | Option exercise | 6,894 | — | — | filing |
| 2025-11-21 | CPRX | CATALYST PHARMACEUTICALS, INC. | Tax withholding | 2,485 | — | — | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.